A laparoscopic procedure was decided on. After preoxygenation, anaesthesia was induced with intravenous alfentanil 1 mg followed by propofol 200 mg. Tracheal intubation was easily performed with a 9 mm cuffed tube and anaesthesia was maintained with oxygen, nitrous oxide and sevoflurane to an end-tidal concentration of 1.0-1.5%. Intermittent positive pressure ventilation was applied to maintain end-tidal carbon dioxide concentration at around 5 kPa and airway pressure was noted to be within normal limits. No neuromuscular blocking agents or further opioids were given. Ketorolac trometamol 15 mg was administered intravenously after induction and again at the end of surgery, when the wounds were infiltrated with 0.5% chirocaine hydrochloride.
At surgery, a standard 4 port technique was used. Because the patient was not given muscle relaxant it was difficult to maintain an adequate pneumoperitoneum at an insufflation pressure of 15 mmHg. The pressure was therefore raised to 20 mmHg with satisfactory results. Throughout the procedure, which lasted about 40 min, the patient remained stable and the operation was completed uneventfully. After return of spontaneous ventilation and removal of the endotracheal tube he was transferred to the high dependency unit for postoperative monitoring. A regimen of diclofenac sodium and paracetamol, by mouth or rectally, was prescribed for postoperative pain relief.
COMMENT
The myotonic dystrophy gene, on chromosome 19, codes for a regulatory protein kinase in skeletal muscle. Affected individuals usually have compromised respiratory function with globally reduced functional residual capacity, functional vital capacity and peak inspiratory pressures. They are exceptionally sensitive to neuromuscular blocking drugs, 1 premedicants and opioids; 2 moreover, the surgeon and anaesthetist must plan carefully to avoid precipitating myotonia by hypothermia, shivering and mechanical or electrical stimulation, before, during or after operation. The anaesthetic technique of choice remains uncertain. There are reports of exaggerated physiological responses 3 and a myotonic state after propofol administration, but we are not the first to use it without ill effects. 4 Other groups, too, have used this agent without muscle relaxants for laparoscopic cholecystectomy; 5 however, in our patient an increase over the standard insufflation pressure was needed to overcome abdominal wall resistance. Clearly gas-less laparoscopic surgery, in which the abdominal wall is raised manually, will not be an option in patients with myotonic dystrophy, because it requires neuromuscular blockade.
Patients with myotonic dystrophy have a high rate of complications from surgery of all kinds, mainly respiratory complications. 2, 6 Men with this condition seem to be at excess risk of gallstone disease requiring surgery. 7 Patient assessment should include detailed cardiovascular evaluation and full pulmonary function tests. Harper 8 has published guidelines for the care of these patients before, during and after surgery. The anti-migraine agent sumatriptan sometimes causes chest tightness, presumed to be secondary to coronary artery spasm. Another proposed factor in coronary artery spasm is thyrotoxicosis. The combination may be hazardous.
Thyrotoxicosis, sumatriptan and coronary artery spasm

CASE HISTORY
A woman aged 45 sought advice after experiencing recurrent headache for eight months. A CT scan was normal and migraine was diagnosed. Eight months later she was admitted to her local hospital with headache, weight loss, palpitations, diarrhoea and episodic non-exertional chest tightness radiating to her jaw. Free thyroxine was hormone was 50.1 mU/L (0.1-5.5), confirming thyrotoxicosis. Her headache was attributed to migraine and, before the thyroid function results were available, she was given oral sumatriptan 50 mg. Forty-five minutes later she had a cardiac arrest with ventricular fibrillation from which she was successfully resuscitated. 24 hours later she was transferred to our centre for further investigation. On admission to the coronary care unit her electrocardiogram (ECG) showed marked anterolateral T wave inversion, and serum troponin I was raised at 54.3 mg/L (0.0-0.15). A transthoracic echocardiogram showed mild to moderate global impairment of both left and right ventricular systolic function. 28 hours post sumatriptan she had two episodes of pulseless electrical activity during which her ECG showed sinus and nodal bradycardia associated with 2 mm transient ST segment elevation. External cardiac massage was administered and both these episodes resolved within one minute.
She was taken to the cardiac catheter laboratory that morning. On arteriography coronary anatomy was normal apart from an ostial left main stem stenosis (Figure 1a ). When guidewires were passed into the anterior descending and distal circumflex coronary arteries there was marked circumflex artery spasm (Figure 1b ) which responded well to intracoronary nitrate. Intravascular ultrasound showed a rim of intimal hyperplasia in the proximal left anterior descending artery, together with a minor degree of negative remodelling. There was marked ostial left main stem narrowing but no significant left main stem atheroma.
These findings were considered to be due to intense ostial left main stem spasm. One might have expected such spasm to reverse with intracoronary isosorbide dinitrate, but repeated injections were unsuccessful. The left main stem obstruction was treated with implantation of a drugeluting coronary stent.
Her haemodynamic status improved and she had no further arrhythmias or chest pain. The thyrotoxicosis was treated with sodium iopodate, dexamethasone and carbimazole, with prompt resolution over the next four days. Four months later she was referred for radioactive iodine treatment, at which time repeat coronary arteriography showed a widely patent left main stem stent without restenosis or other significant coronary abnormality (Figure 1c ).
COMMENT
Hyperthyroidism is associated with cardiac morbidity and mortality, primarily due to cardiomyopathy, atrial arrhythmia and thromboembolism. Patients with hyperthyroidism also present with angina secondary to coexisting atherosclerotic coronary artery disease and enhanced platelet reactivity and adhesiveness. 1 patient had life-threatening coronary artery spasm. Previous case reports have suggested that angina in thyrotoxic patients may be due to coronary artery spasm, 2-6 and in two of these the symptoms and coronary spasm could be reproduced by intracoronary injection of the 5-hydroxytryptamine agonist (5-HT1E) ergonovine maleate. 2, 3 Another such agonist (5-HT1D) is the antimigraine drug sumatriptan, and there have been reports of chest pain and myocardial infarction with its use, 7, 8 thought to be due to coronary artery spasm. This agent, which is rapidly absorbed, is contraindicated in patients with ischaemic heart disease. In the present case, we believe that the episodic non-exertional chest tightness was due to coronary spasm associated with the thyrotoxicosis and that the cardiac arrest was the result of additional spasm induced by sumatriptan. In a patient with thyrotoxicosis and angina, the use of vasoactive agents demands special caution. An occasional associated feature in Hashimoto's thyroiditis is encephalopathy. Whether this amounts to 'Hashimoto's encephalopathy' is disputed.
Encephalopathy with hypothyroidism
CASE HISTORY
A man of 50 was admitted drowsy and confused after experiencing three generalized seizures, each lasting 3-4 minutes, over two days. For the past four months he had been acting strangely, putting things in wrong places, and tremors of the hands had developed. Two months before the present admission he had been admitted elsewhere with a generalized tonic-clonic seizure and disinhibited behaviour, and had been discharged on phenytoin. Thereafter he became withdrawn and stopped speaking. On admission, he was mildly pyrexial and was noted to have bilateral xanthelasma (cholesterol 7.5 mmol/L). He was conscious but drowsy, and disoriented in time, place and person. He was experiencing hallucinations and delusions and displayed disinhibited behaviour. Tremors were seen in all four limbs. Muscle tone, power and reflexes were normal. There was no sensory or cerebellar dysfunction and signs of meningeal irritation were absent. White cell count was 13.2610 9 /L and electrolyte and liver profiles were normal except for a raised gammaglutamyltransferase (296 U/L); blood alcohol was zero and the phenytoin was within the therapeutic range at 15.2 mg/ L. On the electroencephalogram (EEG) there was general slowing consistent with encephalopathy. CT of the head was normal and MRI showed a high signal in the right frontal lobe. Cerebrospinal fluid had a raised protein of 1.67 g/L but there was no pleocytosis; polymerase chain reaction for herpes simplex virus was negative, as were bacterial cultures. He had biochemical evidence of mild hypothyroidism with TSH 17 mU/L (normal 0.35-5.0) and FT4 16.2 mmol/L (11-25). Antithyroid peroxidase antibodies titres were very high at 2699 IU/mL (0-75). Tests for rheumatoid factor, antinuclear antibody, HIV and viral
